Breast Cancer Screening Test Industry Overview
The breast cancer screening test market is moderately competitive and consists of several major players. A few major players currently dominate the market in terms of market share. With the increasing awareness among the population and rising advances in screening tests, a few other smaller players are expected to enter the market and may come to hold a substantial share. The key market players that hold significant shares in the breast cancer screening test market include Koninklijke Philips NV, GE Healthcare, Fujifilm Holdings, and Hologic Inc., among others.
Breast Cancer Screening Test Market Leaders
-
Siemens Healthineers
-
Hologic Inc.
-
General Electric Company
-
Koninklijke Philips NV
-
Fujifilm Holdings
- *Disclaimer: Major Players sorted in no particular order
